Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Accenture
Cantor Fitzgerald
McKesson
Merck
AstraZeneca
Teva
Argus Health
Federal Trade Commission

Generated: May 27, 2018

DrugPatentWatch Database Preview

Iodohippurate sodium i-123 - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for iodohippurate sodium i-123 and what is the scope of iodohippurate sodium i-123 patent protection?

Iodohippurate sodium i-123
is the generic ingredient in one branded drug marketed by Ge Healthcare and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Summary for iodohippurate sodium i-123
Synonyms for iodohippurate sodium i-123
133-17-5
8158AF
AC1Q1HCD
AC1Q1HCE
AC1Q1VWH
Bristol-Myers Squibb Sodium Iodohyppurate (TN)
C9H7INO3.Na
D08081
D0G2MH
EINECS 205-097-5
FT-0728954
Glycin, N-(2-iodobenzoyl)-, monosodium salt
Glycin, N-(2-iodobenzoyl)-, monosodium salt (9CI)
Glycine, N-(2-iodobenzoyl)-, monosodium salt
Glycine, N-(2-iodobenzoyl)-, monosodium salt (9CI)
Hippodin
Hippuran
Hippuran I 131
HIPPURIC ACID, o-IODO-, MONOSODIUM SALT
Hipputope
Iodairal
Iodohippura
Iodohippuran
Iodohippurate sodium
Iodohippurate sodium I 131
Jodairol
LS-75821
Medopaque
N-(2-Iodobenzoyl)glycine monosodium salt
Nephroflow
NSC 63351
o-Iodohippurate sodium
O-Iodohippuric acid sodium salt
o-Jodhippursaeure natrium
o-Jodhippursaeure natrium [German]
OR014110
OR214102
Orthoiodin
Renumbral
SCHEMBL1652159
sodium 2-[(2-iodophenyl)formamido]acetate
Sodium iodohippurate
Sodium o-iodohippurate
SODIUM O-IODOHIPPURATE 99.7%
Sodium orthoiodohippurate
sodium{[2-(125i)iodobenzoyl]amino}acetate
sodium{[2-(131i)iodobenzoyl]amino}acetate
UNII-UVJ3W62NGI
Urocontrast
UVJ3W62NGI

US Patents and Regulatory Information for iodohippurate sodium i-123

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ge Healthcare NEPHROFLOW iodohippurate sodium i-123 INJECTABLE;INJECTION 018289-001 Dec 28, 1984 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Chubb
Daiichi Sankyo
Cerilliant
Deloitte
Cipla
Harvard Business School
McKinsey
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.